How to Fix Drug Ads

If you've ever had doubts about the power of advertising, take a look at a recent study appearing in the Journal of American Medical Association.1 Richard Kravitz, from the University of California, Davis, and colleagues found that when "standardized patient" actors portraying depression visited doctors and asked for Paxil, 27% of them walked out with a prescription for the drug, compared to just 3% of patients who described the same symptoms but did not ask for Paxil. That finding should be con

Written byRichard Gallagher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

If you've ever had doubts about the power of advertising, take a look at a recent study appearing in the Journal of American Medical Association.1 Richard Kravitz, from the University of California, Davis, and colleagues found that when "standardized patient" actors portraying depression visited doctors and asked for Paxil, 27% of them walked out with a prescription for the drug, compared to just 3% of patients who described the same symptoms but did not ask for Paxil. That finding should be considered in the context of the fact that there are three other antidepressants in exactly the same class as Paxil and countless other treatments available, some of which don't involve any medication. Other surveys2 have found that about 40% of patients who asked for a specific drug left their doctor's offices with a prescription for it.

It's no wonder, then, that direct to consumer (DTC) pharmaceutical advertising is a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies